Janux Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	51.83	52.33	430.61	19.21	51.43	35.58
Short-Term Investments	904.56	914.23	594.57	324.82	275.59	339.38
Cash & Short-Term Investments	956.39	966.57	1,025	344.03	327.02	374.97
Cash Growth	-5.70%	-5.72%	197.99%	5.20%	-12.79%	4699.24%
Accounts Receivable	35	-	-	-	-	-
Other Current Assets	10.66	9.32	8.49	5.21	5.42	2.05
Total Current Assets	1,002	975.89	1,034	349.24	332.44	377.02
Net Property, Plant & Equipment	21.42	22.25	24.15	27.84	29.37	1.6
Other Long-Term Assets	4.76	3.42	3.7	3.33	2.21	1.21
Total Assets	1,028	1,002	1,062	380.41	364.01	379.82
Accounts Payable	3.38	4.97	4.03	2.42	2.16	2.46
Accrued Expenses	15.48	17.63	11.68	7.39	8.18	3.78
Current Portion of Leases	2.47	2.39	1.75	1.52	0.76	0.19
Unearned Revenue	37.59	-	-	1.71	5.41	5.16
Other Current Liabilities	-	-	-	-	-	1.2
Total Current Liabilities	58.92	25	17.46	13.03	16.51	12.8
Long-Term Leases	19.1	19.75	21.28	23.03	24.54	-
Other Long-Term Liabilities	8.68	-	-	-	2.22	0.7
Total Long-Term Liabilities	27.78	19.75	21.28	23.03	26.76	0.7
Total Liabilities	86.69	44.74	38.74	36.06	43.27	13.5
Common Stock	0.06	0.06	0.06	0.05	0.04	0.04
Additional Paid-in Capital	1,317	1,304	1,258	512.4	432.7	413.97
Accumulated Other Comprehensive Income	0.58	2.16	4.32	0.67	-1.54	-0.27
Retained Earnings	-375.74	-351.38	-237.76	-168.76	-110.47	-47.41
Total Common Shareholders' Equity	941.54	956.82	1,023	344.35	320.74	366.33
Shareholders' Equity	941.54	956.82	1,023	344.35	320.74	366.33
Total Liabilities & Equity	1,028	1,002	1,062	380.41	364.01	379.82
Total Debt	21.57	22.14	23.03	24.54	25.31	0.19
Net Cash (Debt)	934.82	944.43	1,002	319.49	301.71	374.77
Net Cash Growth	-5.72%	-5.76%	213.68%	5.89%	-19.50%	4696.76%
Net Cash Per Share	15.03	15.24	18.64	7.26	7.28	15.93
Book Value	941.54	956.82	1,023	344.35	320.74	366.33
Book Value Per Share	15.14	15.44	19.03	7.82	7.73	15.57
Tangible Book Value	941.54	956.82	1,023	344.35	320.74	366.33
Tangible Book Value Per Share	15.14	15.44	19.03	7.82	7.73	15.57

SEC Filings: 10-K · 10-Q